Clinical Trial Update: Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ticagrelor versus clopidogrel in patients after ST-elevation myocardial infarction to assess left ventricular remodeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Brilinta (ticagrelor) (ticagrelor)
• Plavix (clopidogrel) (clopidogrel)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: ST Elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN